Langsted A1, Freiberg JJ2, Nordestgaard BG3.
Atherosclerosis. 2016 Nov 24;257:9-15. doi: 10.1016/j.atherosclerosis.2016.11.025. [Epub ahead of print]BACKGROUND AND AIMS: We estimated the extent of undertreatment and overtreatment with cholesterol-lowering therapy according to European guidelines in individuals in the Danish general population without ischemic cardiovascular disease and diabetes.METHODS: We examined 92,348 such individuals aged 35-100 years recruited from 2004 through 2014 in the Copenhagen General Population Study. Each individual was assigned their 10-year risk of fatal cardiovascular disease according to the European SCORE chart based on age, sex, smoking, total cholesterol, and systolic blood pressure. Read More